您搜索了: méthylnortestostérone (法语 - 英语)

liste de substances dopantes et de méthodes de dopage interdites entrée en vigueur le 1er janvier 2006* l'utilisation de tout médicament devrait être limitée à des indications médicalement justifiées substances et mÉthodes interdites en permanence (en et hors compÉtition) substances interdites s1. agents anabolisants les agents anabolisants sont interdits. 1. stéroïdes anabolisants androgènes (saa) a. saa exogènes*, incluant: 1-androstènediol (5α-androst-1-ène-3β,17β-diol ); 1-androstènedione (5α-androst-1-ène-3,17-dione); bolandiol (19-norandrostènediol); bolastérone; boldénone; boldione (androsta-1,4-diène-3,17-dione); calustérone; clostébol; danazol (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazole); déhydrochlorméthyltestostérone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one); désoxyméthyltestostérone (17α-methyl-5α-androst-2-en-17β-ol); drostanolone; éthylestrénol (19-nor-17α-pregn-4-en-17-ol); fluoxymestérone; formébolone; furazabol (17β-hydroxy-17α-methyl-5α-androstano[2,3-c]-furazan); gestrinone; 4-hydroxytestostérone (4,17β-dihydroxyandrost-4-en-3-one); mestanolone; mestérolone; méténolone; méthandiénone (17β-hydroxy-17α-methylandrosta-1,4-diène-3-one); méthandriol; méthastérone (2α, 17α-dimethyl-5α-androstane-3-one-17β-ol); méthyldiénolone (17β-hydroxy-17α-methylestra-4,9-diène-3-one); méthyl-1-testostérone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one); méthylnortestostérone (17β-hydroxy-17α-methylestr-4-en-3-one); méthyltriénolone (17β-hydroxy-17α-methylestra-4,9,11-triène-3-one); méthyltestostérone; mibolérone; nandrolone; 19-norandrostènedione (estr-4-ène-3,17-dione); norbolétone; norclostébol; noréthandrolone; oxabolone; oxandrolone; oxymestérone; oxymétholone; prostanozol ([3,2-c]pyrazole-5α-etioallocholane-17β-tetrahydropyranol); quinbolone; stanozolol; stenbolone; 1-testostérone (17β-hydroxy-5α-androst-1-ène-3-one); tétrahydrogestrinone (18a-homo-pregna-4,9,11-triène-17β-ol-3-one); trenbolone et autres substances possédant une structure chimique similaire ou un (des) effet(s) biologique(s) similaire(s). b. saa endogènes**: androstènediol (androst-5-ène-3β,17β-diol); androstènedione (androst-4-ène-3,17-dione); dihydrotestostérone (17β-hydroxy-5α-androstan-3-one); prastérone (déhydroépiandrostérone, dhea); testostérone et les métabolites ou isomères suivants: 5α-androstane-3α,17α-diol; 5α-androstane-3α,17β-diol; 5α-androstane-3β,17α-diol; 5α-androstane-3β,17β-diol; androst-4-ène-3α,17α-diol; androst-4-ène-3α,17β-diol; androst-4-ène-3β,17α-diol; androst-5-ène-3α,17α-diol; androst-5-ène-3α,17β-diol; androst-5-ène-3β,17α-diol; 4-androstènediol (androst-4-ène-3β,17β-diol); 5-androstènedione (androst-5-ène-3,17-dione); épi-dihydrotestostérone; 3α-hydroxy-5α-androstan-17-one; 3β-hydroxy-5α-androstan-17-one; 19-norandrostérone; 19-norétiocholanolone. dans le cas d’un stéroïde anabolisant androgène pouvant être produit de façon endogène, un échantillon sera considéré comme contenant cette substance interdite si la concentration de ladite substance interdite ou de ses métabolites ou de ses marqueurs et/ou tout autre rapport pertinent dans l’échantillon du sportif s’écarte suffisamment des valeurs normales trouvées chez l’homme pour qu'une production endogène normale soit improbable.
list of prohibited substances and methods valid 1 january 2006* the use of any drug should be limited to medically justified indications substances and methods prohibited at all times (in- and out-of-competition) prohibited substances s1. anabolic agents anabolic agents are prohibited. 1. anabolic androgenic steroids (aas) a. exogenous* aas, including: 1-androstendiol (5α-androst-1-ene-3β,17β-diol ); 1-androstendione (5α-androst-1-ene-3,17-dione); bolandiol (19-norandrostenediol); bolasterone; boldenone; boldione (androsta-1,4-diene-3,17-dione); calusterone; clostebol; danazol (17α-ethynyl-17β-hydroxyandrost-4-eno[2,3-d]isoxazole); dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one); desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol); drostanolone; ethylestrenol (19-nor-17α-pregn-4-en-17-ol); fluoxymesterone; formebolone; furazabol (17β-hydroxy-17α-methyl-5α-androstano[2,3-c]-furazan); gestrinone; 4-hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one); mestanolone; mesterolone; metenolone; methandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one); methandriol; methasterone (2α, 17α-dimethyl-5α-androstane-3-one-17β-ol); methyldienolone (17β-hydroxy-17α-methylestra-4,9-dien-3-one); methyl-1-testosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one); methylnortestosterone (17β-hydroxy-17α-methylestr-4-en-3-one); methyltrienolone (17β-hydroxy-17α-methylestra-4,9,11-trien-3-one); methyltestosterone; mibolerone; nandrolone; 19-norandrostenedione (estr-4-ene-3,17-dione); norboletone; norclostebol; norethandrolone; oxabolone; oxandrolone; oxymesterone; oxymetholone; prostanozol ([3,2-c]pyrazole-5α-etioallocholane-17β-tetrahydropyranol); quinbolone; stanozolol; stenbolone; 1-testosterone (17β-hydroxy-5α-androst-1-en-3-one); tetrahydrogestrinone (18a-homo-pregna-4,9,11-trien-17β-ol-3-one); trenbolone and other substances with a similar chemical structure or similar biological effect(s). b. endogenous** aas: androstenediol (androst-5-ene-3β,17β-diol); androstenedione (androst-4-ene-3,17-dione); dihydrotestosterone (17β-hydroxy-5α-androstan-3-one) ; prasterone (dehydroepiandrosterone, dhea); testosterone and the following metabolites and isomers: 5α-androstane-3α,17α-diol; 5α-androstane-3α,17β-diol; 5α-androstane-3β,17α-diol; 5α-androstane-3β,17β-diol; androst-4-ene-3α,17α-diol; androst-4-ene-3α,17β-diol; androst-4-ene-3β,17α-diol; androst-5-ene-3α,17α-diol; androst-5-ene-3α,17β-diol; androst-5-ene-3β,17α-diol; 4-androstenediol (androst-4-ene-3β,17β-diol); 5-androstenedione (androst-5-ene-3,17-dione); epi-dihydrotestosterone; 3α-hydroxy-5α-androstan-17-one; 3β-hydroxy-5α-androstan-17-one; 19-norandrosterone; 19-noretiocholanolone. where an anabolic androgenic steroid is capable of being produced endogenously, a sample will be deemed to contain such prohibited substance where the concentration of such prohibited substance or its metabolites or markers and/or any other relevant ratio(s) in the athlete’s sample so deviates from the range of values normally found in humans that it is unlikely to be consistent with normal endogenous production.